Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002. Bone Marrow Transplant 2023 Dec;58(12):1416-1418

Date

09/26/2023

Pubmed ID

37749187

DOI

10.1038/s41409-023-02110-4

Scopus ID

2-s2.0-85172133108 (requires institutional sign-in at Scopus site)   1 Citation

Author List

Meyers G, Hamadani M, Martens M, Ali H, Chevallier P, Choe H, Harris AC, Holler E, van Hooren E, Klaassen W, Leifer E, van Oosterhout Y, Perez L, Pusic I, Stelljes M, van der Velden W, Ammatuna E, Beauvais D, Cornillon J, Maziarz RT, Schetelig J, Romeril J, MacMillan ML, Levine JE, Socié G

Authors

Mehdi H. Hamadani MD Professor in the Medicine department at Medical College of Wisconsin
Michael Martens PhD Assistant Professor in the Institute for Health and Equity department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Bone Marrow Transplantation
Graft vs Host Disease
Humans
Immunoconjugates
Steroids